Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2014, Vol. 8 Issue (4) : 419-426     DOI: 10.1007/s11684-014-0383-6
REVIEW |
Aneurysmal dilatation of the aortic sinuses of Valsalva — beyond Marfan syndrome: a single centre experience and review of the literature
Maryanne Caruana1,*(),Mary N. Sheppard2,Wei Li1
1. Department of Cardiology, Mater Dei Hospital, Birkirkara Bypass, Birkirkara MSD 2090, Malta
2. Imperial Cardiac Pathology Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
3. Adult Congenital Heart Disease Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
Download: PDF(573 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  

Aneurysmal dilatation of the aortic sinuses of Valsalva has been most extensively documented in the setting of aortopathies, particularly Marfan syndrome. On the other hand, there is limited data in the literature about congenital sinus of Valsalva aneurysms outside this context. For the purpose of this review, we carried out a literature search on aneurysmal dilatation of the sinuses of Valsalva in Marfan syndrome, and compared this with congenital sinus of Valsalva aneurysms, also including data from a case series from our institution. In conclusion, there are differences in management of aortic dilatation in Marfan syndrome and congenital sinus of Valsalva aneurysms. Though less well-recognised, congenital aneurysms are often associated with significant morbidity and mortality and timely intervention is necessary.

Keywords sinus of Valsalva aneurysms      Marfan syndrome      aortic dissection     
Corresponding Authors: Maryanne Caruana   
Just Accepted Date: 06 November 2014   Online First Date: 01 December 2014    Issue Date: 18 December 2014
URL:  
http://academic.hep.com.cn/fmd/EN/10.1007/s11684-014-0383-6     OR     http://academic.hep.com.cn/fmd/EN/Y2014/V8/I4/419
Case No. Sex Age (year) SoV involved Findings on investigation Underlying congenital defects/ conditions Clinical presentation
Dissection
1 M 29 RC 2 dissection tears above aortic valve+ hemopericardium “Connective tissue disorder” (non-Marfan) Sudden death
2 M 34 RC+ NC Dissection with tear in NC SoV+ hemopericardium - Sudden death
3 M 46 LC+ RC Dissection+ thrombus in LC SVA - Out of hospital cardiac arrest
Aneurysm rupture
4 F 32 RC SVA rupture into RVOT BAV+ AR Heart failure
5 M 39 NC SVA rupture into RA BAV+ AR Heart failure
6 M 36 RC SVA rupture into RVOT Resected SAS Right-sided failure
7 M 46 RC SVA rupture into RV body+ RA - Heart failure
8 F 25 RC SVA rupture into RV body VSD (subaortic perimembranous) Heart failure
9 F 33 NC Ruptured NC SVA with hemopericardium Klippel-Feil syndrome & HT Sudden death
10 F 48 NC Small SVA rupture into RA - Asymptomatic
11 F 27 RC Small SVA rupture into RV body VSD (small muscular VSD) Asymptomatic
Other
12 M 38 RC+ LC+ NC RCA stretched over aneurysm with no occlusion; no histological ventricular changes - Sudden death
Tab.1  Clinical manifestation of sinus of Valsalva aneurysmsa
Fig.1  Postmortem image for case 2 showing aneurysms of right coronary (RC) and non-coronary (NC) sinuses (labeled) with a dissection tear in the non-coronary sinus leading to hemopericardium (asterisk). (Reprinted from Ref. [3] with permission.)
Fig.2  Postmortem image for case 9 showing site of rupture (arrow) of the free wall of non-coronary sinus of Valsalva (NC) (labeled) resulting in a large hemopericardium. (Reprinted from Ref. [3] with permission.)
Fig.3  Two-dimensional transesophageal echocardiogram from case 3 showing aneurysmal dilatation of left coronary sinus with thrombus (arrow) in situ. (Reprinted from Ref. [3]. with permission.)
Fig.4  Computed tomographic angiogram with three-dimensional reconstruction from case 3 showing a large left coronary sinus of Valsalva aneurysm measuring 45mm in its maximum diameter and a smaller right coronary sinus aneurysm measuring 23mm in its maximum diameter (labeled) with stretching of the left coronary artery. (Reprinted from Ref. [3] with permission.)
1 Ho SY. Structure and anatomy of the aortic root. Eur J Echocardiogr2009; 10(1): i3–i10
doi: 10.1093/ejechocard/jen243 pmid: 19131496
2 Bricker AO, Avutu B, Mohammed TLH, Williamson EE, Syed IS, Julsrud PR, Schoenhagen P, Kirsch J. Valsalva sinus aneurysms: findings at CT and MR imaging. Radiographics2010; 30(1): 99– 110
doi: 10.1148/rg.301095719 pmid: 20083588
3 Caruana M, Sheppard M, Li W. Sinus of Valsalva aneurysms in non-Marfan patients: an underestimated entity? A case series. Br J Med Med Res2014; 4(7): 1448–1459
doi: 10.9734/BJMMR/2014/7057
4 Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM. The revised Ghent nosology for the Marfan syndrome. J Med Genet2010; 47(7): 476–485
doi: 10.1136/jmg.2009.072785 pmid: 20591885
5 Hope J. A Treatise on the Diseases of the Heart and Great Vessels, and on the Affections which May be Mistaken for Them. 3rd ed. Churchill. 1839
6 Mayer ED, Ruffmann K, Saggau W, Butzmann B, Bernhardt-Mayer K, Schatton N, Schmitz W. Ruptured aneurysms of the sinus of Valsalva. Ann Thorac Surg1986; 42(1): 81–85
doi: 10.1016/S0003-4975(10)61842-5 pmid: 3729620
7 Dong C, Wu QY, Tang Y. Ruptured sinus of valsalva aneurysm: a Beijing experience. Ann Thorac Surg2002; 74(5): 1621–1624
doi: 10.1016/S0003-4975(02)03987-5 pmid: 12440619
8 Takach TJ, Reul GJ, Duncan JM, Cooley DA, Livesay JJ, Ott DA, Frazier OH. Sinus of Valsalva aneurysm or fistula: management and outcome. Ann Thorac Surg1999; 68(5): 1573–1577
doi: 10.1016/S0003-4975(99)01045-0 pmid: 10585023
9 Moustafa S, Mookadam F, Cooper L, Adam G, Zehr K, Stulak J, Holmes D. Sinus of Valsalva aneurysms—47 years of a single center experience and systematic overview of published reports. Am J Cardiol2007; 99(8): 1159–1164
doi: 10.1016/j.amjcard.2006.11.047 pmid: 17437748
10 Nenci I, Malaguti R. Congenital aneurysm of Valsalva’s sinus in the Klippel-Feil syndrome. Riv Patol Clin Sper1967; 8(4): 493–517 (in Italian)
pmid: 5605968
11 Kawano Y, Tamura A, Kadota J. Klippel-Feil syndrome accompanied by an aneurysm of the non-coronary sinus of Valsalva. Intern Med2006; 45(20): 1191–1192
doi: 10.2169/internalmedicine.45.6135 pmid: 17106170
12 Roussin I, Sheppard MN, Rubens M, Kaddoura S, Pepper J, Mohiaddin RH. Cardiovascular complications of cutis laxa syndrome: successful diagnosis and surgical management. Circulation2011; 124(1): 100–102
doi: 10.1161/CIRCULATIONAHA.111.025056 pmid: 21730323
13 Dobrilovic N, Fernandez AB, Lin A, Singh AK. Treacher Collins syndrome: sinus of Valsalva aneurysm. Circulation2013; 128(2): e12–e13
doi: 10.1161/CIRCULATIONAHA.113.001588 pmid: 23836833
14 Dias R, Camurca F, Leite Filho, Stolf N. Right sinus of Valsalva aneurysm causing extrinsic coronary compression. Arg Bras Cardiol2009; 92(6): e47–50, e74–7
15 Schlatmann TJ, Becker AE. Pathogenesis of dissecting aneurysm of aorta. Comparative histopathologic study of significance of medial changes. Am J Cardiol1977; 39(1): 21–26
doi: 10.1016/S0002-9149(77)80005-2 pmid: 831424
16 Erdheim J. Medionecrosis aortae idiopathica. Virchows Arch1929; 273(2): 454–479 (in German)
doi: 10.1007/BF02158989
17 Davies RR, Gallo A, Coady MA, Tellides G, Botta DM, Burke B, Coe MP, Kopf GS, Elefteriades JA. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg2006; 81(1): 169–177
doi: 10.1016/j.athoracsur.2005.06.026 pmid: 16368358
18 Meijboom LJ, Timmermans J, Zwinderman AH, Engelfriet PM, Mulder BJM. Aortic root growth in men and women with the Marfan’s syndrome. Am J Cardiol2005; 96(10): 1441–1444
doi: 10.1016/j.amjcard.2005.06.094 pmid: 16275195
19 Nienaber C, Haverich A, Erbel R. Diseases of the aorta and trauma to the aorta and the heart. In: Camm J, Luscher T, Serruys P. The ESC Textbook of Cardiovascular Medicine. Oxford: Blackwell Publishing Ltd, 2006: 993–1031
20 Lijoi A, Parodi E, Passerone GC, Scarano F, Caruso D, Iannetti MV. Unruptured aneurysm of the left sinus of valsalva causing coronary insufficiency: case report and review of the literature. Tex Heart Inst J2002; 29(1): 40–44
pmid: 11995849
21 Pepper C, Munsch C, Sivananthan UM, Pye M. Unruptured aneurysm of the left sinus of Valsalva extending into the left ventricular outflow tract: presentation and imaging. Heart1998; 80(2): 190–193
doi: 10.1136/hrt.80.2.190 pmid: 9813568
22 Thankachen R, Gnanamuthu R, Doshi H, Shukla V, Korula RJ. Unruptured aneurysm of the sinus of Valsalva presenting with right ventricular outflow obstruction. Tex Heart Inst J2003; 30(2): 152–154
pmid: 12809262
23 Haraphongse M, Ayudhya RK, Jugdutt B, Rossall RE. Isolated unruptured sinus of Valsalva aneurysm producing right ventricular outflow obstruction. Cathet Cardiovasc Diagn1990; 19(2): 98–102
doi: 10.1002/ccd.1810190208 pmid: 2407367
24 Pasteuning WH, Roukema JA, van Straten AHM, van der MA, Wonnink-de Jonge WF. Rapid hemodynamic deterioration because of acute rupture of an aneurysm of the sinus of Valsalva: the importance of echocardiography in early diagnosis. J Am Soc Echocardiogr2002; 15(10): 1108–1110
doi: 10.1067/mje.2002.122964 pmid: 12373255
25 Devereux RB, de Simone G, Arnett DK, Best LG, Boerwinkle E, Howard BV, Kitzman D, Lee ET, Mosley TH Jr, Weder A, Roman MJ. Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons≥15 years of age. Am J Cardiol2012; 110(8): 1189–1194
doi: 10.1016/j.amjcard.2012.05.063 pmid: 22770936
26 Baumgartner H, Bonhoeffer P, De Groot NMS, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, McDonagh T, Swan L, Andreotti F, Beghetti M, Borggrefe M, Bozio A, Brecker S, Budts W, Hess J, Hirsch R, Jondeau G, Kokkonen J, Kozelj M, Kucukoglu S, Laan M, Lionis C, Metreveli I, Moons P, Pieper PG, Pilossoff V, Popelova J, Price S, Roos-Hesselink J, Uva MS, Tornos P, Trindade PT, Ukkonen H, Walker H, Webb GD, Westby J; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC); ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J2010; 31(23): 2915–2957
doi: 10.1093/eurheartj/ehq249 pmid: 20801927
27 Milewicz DM, Dietz HC, Miller DC. Treatment of aortic disease in patients with Marfan syndrome. Circulation2005; 111(11): e150–e157
doi: 10.1161/01.CIR.0000155243.70456.F4 pmid: 15781745
28 Rossi-Foulkes R, Roman MJ, Rosen SE, Kramer-Fox R, Ehlers KH, O’Loughlin JE, Davis JG, Devereux RB. Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome. Am J Cardiol1999; 83(9): 1364–1368
doi: 10.1016/S0002-9149(99)00101-0 pmid: 10235096
29 Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med1994; 330(19): 1335–1341
doi: 10.1056/NEJM199405123301902 pmid: 8152445
30 Gersony DR, McClaughlin MA, Jin Z, Gersony WM. The effect of beta-blocker therapy on clinical outcome in patients with Marfan’s syndrome: a meta-analysis. Int J Cardiol2007; 114(3): 303–308
doi: 10.1016/j.ijcard.2005.11.116 pmid: 16831475
31 Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC 3rd. Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome. N Engl J Med2008; 358(26): 2787–2795
doi: 10.1056/NEJMoa0706585 pmid: 18579813
32 Groenink M, den Hartog AW, Franken R, Radonic T, de Waard V, Timmermans J, Scholte AJ, van den Berg MP, Spijkerboer AM, Marquering HA, Zwinderman AH, Mulder BJ. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J2013; 34(45): 3491–3500
doi: 10.1093/eurheartj/eht334 pmid: 23999449
33 Mullen MJ, Flather MD, Jin XY, Newman WG, Erdem G, Gaze D, Valencia O, Banya W, Foley CE, Child A. A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol. Trials2013; 14(1): 408
doi: 10.1186/1745-6215-14-408 pmid: 24289736
No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed